In a mouse model of AD and in vitro cultured microglia, RIPK1 inhibition was shown to attenuate the DAM response and to enhance phagocyte activity to clear Aβ (Ofengeim et al., 2017). The gene discussed is RIPK1; the disease is Alzheimer disease.